Literature DB >> 9799322

Use of technetium-tagged white blood cells in patients with Crohn's disease and ulcerative colitis: is differential diagnosis possible?

M Charron1, J F del Rosario, S Kocoshis.   

Abstract

BACKGROUND: Studies have suggested that scans with technetium-tagged white blood cells (WBC-Tc99m) may be equal to endoscopy in the assessment of extent and activity of inflammatory bowel disease (IBD).
OBJECTIVE: We have retrospectively examined the accuracy of WBC-Tc99m scans in differentiating continuous from discontinuous colitis in pediatric IBD.
MATERIALS AND METHODS: There were 207 children in the study (96 boys, 111 girls, median age 13 years). This included 29 controls - children with no gastrointestinal disease (NL) who underwent WBC-Tc99m scans for other medical problems. Scans were obtained at 30 minutes and 2-4 hours following injection. Scans were interpreted as showing continuous colitis, discontinuous colitis, or no colitis.
RESULTS: In the 77 children with active Crohn's disease (CD) of the colon, the scans revealed discontinuous uptake in 63 children and continuous uptake in 14. In the 29 children with ulcerative colitis (UC), 23 scans showed continuous uptake and 6 revealed discontinuous uptake. Two of these 6 showed focal activity near the appendix, and subclinical appendicitis could not be excluded. Another child was bleeding and the scan could have been misinterpreted as showing small- bowel inflammation. In the last three patients, skip areas were clearly identifiable. In none of these last three patients were the biopsies typical of CD (i. e., no granuloma was identified) nor was inflammation patchy. In summary, of the 106 scans showing inflammation, 6 were classified into the wrong group.
CONCLUSION: These data show that WBC-Tc99m scanning can be useful in distinguishing discontinuous from continuous colitis.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9799322     DOI: 10.1007/s002470050486

Source DB:  PubMed          Journal:  Pediatr Radiol        ISSN: 0301-0449


  6 in total

Review 1.  Role of scintigraphy in inflammatory bowel disease.

Authors:  Maria I Stathaki; Sophia I Koukouraki; Nikolaos S Karkavitsas; Ioannis E Koutroubakis
Journal:  World J Gastroenterol       Date:  2009-06-14       Impact factor: 5.742

Review 2.  Technetium leukocyte imaging in inflammatory bowel disease.

Authors:  M Charron
Journal:  Curr Gastroenterol Rep       Date:  1999-06

3.  99mTc-HMPAO leucocyte scintigraphy fails to detect Crohn's disease in the proximal gastrointestinal tract.

Authors:  S M Davison; S Chapman; M S Murphy
Journal:  Arch Dis Child       Date:  2001-07       Impact factor: 3.791

4.  In vivo imaging of mucosal CD4+ T cells using single photon emission computed tomography in a murine model of colitis.

Authors:  Bittoo Kanwar; Dong Wei Gao; Andrew B Hwang; James P Grenert; Simon P Williams; Benjamin Franc; Joseph M McCune
Journal:  J Immunol Methods       Date:  2007-10-16       Impact factor: 2.303

5.  Role of molecular imaging in the management of patients affected by inflammatory bowel disease: State-of-the-art.

Authors:  Federico Caobelli; Laura Evangelista; Natale Quartuccio; Demetrio Familiari; Corinna Altini; Angelo Castello; Mariapaola Cucinotta; Rossella Di Dato; Cristina Ferrari; Aurora Kokomani; Iashar Laghai; Riccardo Laudicella; Silvia Migliari; Federica Orsini; Salvatore Antonio Pignata; Cristina Popescu; Erinda Puta; Martina Ricci; Silvia Seghezzi; Alessandro Sindoni; Martina Sollini; Letterio Sturiale; Anna Svyridenka; Vittoria Vergura; Pierpaolo Alongi
Journal:  World J Radiol       Date:  2016-10-28

6.  Radiolabeled Cationic Peptides for Targeted Imaging of Infection.

Authors:  Tolulope A Aweda; Zumrut F B Muftuler; Adriana V F Massicano; Dhruval Gadhia; Kelly A McCarthy; Stacy Queern; Anupam Bandyopadhyay; Jianmin Gao; Suzanne E Lapi
Journal:  Contrast Media Mol Imaging       Date:  2019-10-29       Impact factor: 3.161

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.